| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Divisions of Ophthalmology (Dr. Söderström) and Neurology (Drs. Ya-Ping, Hillert, and Link), Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
We investigated the paraclinical profile of monosymptomatic optic neuritis(ON) and its prognosis for multiple sclerosis (MS). The correct identification of patients with very early MS carrying a high risk for conversion to clinically definite MS is important when new treatments are emerging that hopefully will prevent or at least delay future MS. We conducted a prospective single observer and population-based study of 147 consecutive patients (118 women, 80%) with acute monosymptomatic ON referred from a catchment area of 1.6 million inhabitants between January 1, 1990 and December 31, 1995. Of 116 patients examined with brain MRI, 64 (55%) had three or more high signal lesions, 11 (9%) had one to two high signal lesions, and 41 (35%) had a normal brain MRI. Among 143 patients examined, oligoclonal IgG (OB) bands in CSF only were demonstrated in 103 patients (72%). Of 146 patients analyzed, 68 (47%) carried the DR15,DQ6,Dw2 haplotype. During the study period, 53 patients (36%) developed clinically definite MS. The presence of three or more MS-like MRI lesions as well as the presence of OB were strongly associated with the development of MS (p < 0.001). Also, Dw2 phenotype was related to the development of MS (p = 0.046). MRI and CSF studies in patients with ON give clinically important information regarding the risk for future MS.
Supported by the Swedish Medical Association, the Swedish MS Society(NHR), the Swedish Society for Medical Research, the Swedish Medical Research Council (project no. 12230), and funds from Karolinska Institute.
Received December 16, 1996. Accepted in final form September 5, 1997.
Address correspondense and reprint requests to Dr. M. Söderström, Division of Ophthalmology, Huddinge Hospital, S-14186 Huddinge, Sweden.
This article has been cited by other articles:
|
|
 |
|
  M. Zandian, R. Belisle, K. R. Mott, S. Nusinowitz, F. M. Hofman, and H. Ghiasi Optic Neuritis in Different Strains of Mice by a Recombinant HSV-1 Expressing Murine Interleukin-2 Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3275 - 3282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Tintore and J Sastre-Garriga Role of MRI criteria and OB for diagnosing multiple sclerosis in patients presenting with clinically isolated syndromes Multiple Sclerosis, April 1, 2009; 15(4): 407 - 408. [PDF]
|
|
|
|
 |
|
 B. J. OSBORNE and N. J. VOLPE Optic neuritis and risk of MS: Differential diagnosis and management Cleveland Clinic Journal of Medicine, March 1, 2009; 76(3): 181 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Miller, B. Weinshenker, M Filippi, B. Banwell, J. Cohen, M. Freedman, S. Galetta, M Hutchinson, R. Johnson, L Kappos, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach Multiple Sclerosis, November 1, 2008; 14(9): 1157 - 1174. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Q. Hintzen and G. Giovannoni CSF analysis in suspected MS: Do bands aid? Neurology, March 25, 2008; 70(13_Part_2): 1059 - 1060. [Full Text] [PDF]
|
|
|
|
|
|
M. Tintore, A. Rovira, J. Rio, C. Tur, R. Pelayo, C. Nos, N. Tellez, H. Perkal, M. Comabella, J. Sastre-Garriga, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology, March 25, 2008; 70(13_Part_2): 1079 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Tuwir, C. Dunne, J. Crowley, T. Saddik, R. Murphy, and L. Cassidy The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis Br J Ophthalmol, October 1, 2007; 91(10): 1288 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Pelayo, M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, N. Tellez, M. Comabella, and X. Montalban Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort Multiple Sclerosis, July 1, 2007; 13(6): 731 - 736. [Abstract] [PDF]
|
|
|
|
 |
|
 J K Swanton, K Fernando, C M Dalton, K A Miszkiel, A J Thompson, G T Plant, and D H Miller Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison J. Neurol. Neurosurg. Psychiatry, September 1, 2006; 77(9): 1070 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Freedman, E. J. Thompson, F. Deisenhammer, G. Giovannoni, G. Grimsley, G. Keir, S. Ohman, M. K. Racke, M. Sharief, C. J. M. Sindic, et al. Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement Arch Neurol, June 1, 2005; 62(6): 865 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shao, Z. Huang, S. L. Sun, H. J. Kaplan, and D. Sun Myelin/Oligodendrocyte Glycoprotein-Specific T-Cells Induce Severe Optic Neuritis in the C57Bl/6 Mouse Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4060 - 4065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Teuscher, J. Y. Bunn, P. D. Fillmore, R. J. Butterfield, J. F. Zachary, and E. P. Blankenhorn Gender, Age, and Season at Immunization Uniquely Influence the Genetic Control of Susceptibility to Histopathological Lesions and Clinical Signs of Experimental Allergic Encephalomyelitis: Implications for the Genetics of Multiple Sclerosis Am. J. Pathol., November 1, 2004; 165(5): 1593 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Yarilin, J. Valiando, and D. N. Posnett A Mouse Herpesvirus Induces Relapse of Experimental Autoimmune Arthritis by Infection of the Inflammatory Target Tissue J. Immunol., October 15, 2004; 173(8): 5238 - 5246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kheradvar, A. R. Tabassi, B. Nikbin, F. Khosravi, M. Naroueynejad, B. Moradi, and A. A. Amirzargar Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study Multiple Sclerosis, October 1, 2004; 10(5): 526 - 531. [Abstract] [PDF]
|
|
|
|
|
|
E T Lim, D Grant, M Pashenkov, G Keir, E J Thompson, M Soderstrom, and G Giovannoni Cerebrospinal fluid levels of brain specific proteins in optic neuritis Multiple Sclerosis, June 1, 2004; 10(3): 261 - 265. [Abstract] [PDF]
|
|
|
|
|
|
M. Eriksson, O. Andersen, and B. Runmarker Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis Multiple Sclerosis, June 1, 2003; 9(3): 260 - 274. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Bettelli, M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo Myelin Oligodendrocyte Glycoprotein-specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis J. Exp. Med., May 5, 2003; 197(9): 1073 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y P Jin, J de Pedro-Cuesta, Y H Huang, and M Soderstrom Predicting multiple sclerosis at optic neuritis onset Multiple Sclerosis, April 1, 2003; 9(2): 135 - 141. [Abstract] [PDF]
|
|
|
|
|
|
L. M. Villar, J. Masjuan, P. Gonzalez-Porque, J. Plaza, M. C. Sadaba, E. Roldan, A. Bootello, and J. C. Alvarez-Cermeno Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS Neurology, August 27, 2002; 59(4): 555 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Tintore, A Rovira, L Brieva, E Grive, R Jardi, C Borras, and X Montalban Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS Multiple Sclerosis, December 1, 2001; 7(6): 359 - 363. [Abstract] [PDF]
|
|
|
|
|
|
A. Martinez-Yelamos, A. Saiz, R. Sanchez-Valle, V. Casado, J. M. Ramon, F. Graus, and T. Arbizu 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis Neurology, August 28, 2001; 57(4): 722 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pashenkov, Y.-M. Huang, V. Kostulas, M. Haglund, M. Soderstrom, and H. Link Two subsets of dendritic cells are present in human cerebrospinal fluid Brain, March 1, 2001; 124(3): 480 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Achiron and Y. Barak Multiple Sclerosis--From Probable to Definite Diagnosis: A 7-Year Prospective Study Arch Neurol, July 1, 2000; 57(7): 974 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. I. Kaufman, J. D. Trobe, E. R. Eggenberger, and J. N. Whitaker Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis: Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, June 13, 2000; 54(11): 2039 - 2044. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Iannucci, C. Tortorella, M. Rovaris, M. P. Sormani, G. Comi, and M. Filippi Prognostic Value of MR and Magnetization Transfer Imaging Findings in Patients withClinically Isolated Syndromes Suggestive ofMultiple Sclerosis at Presentation AJNR Am. J. Neuroradiol., June 1, 2000; 21(6): 1034 - 1038. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. Hauser, J. R. Oksenberg, R. Lincoln, J. Garovoy, R. W. Beck, S. R. Cole, P. S. Moke, K. E. Kip, R. L. Gal, and D. T. Long Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS Neurology, May 9, 2000; 54(9): 1859 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W I McDonald Physicians, subsequence and consequence J. Neurol. Neurosurg. Psychiatry, September 1, 1999; 67(3): 282 - 289. [Full Text]
|
|
|
|
|
|
Y.-P. Jin, J. de Pedro-Cuesta, M. Soderstrom, and H. Link Incidence of Optic Neuritis in Stockholm, Sweden, 1990-1995: II. Time and Space Patterns Arch Neurol, August 1, 1999; 56(8): 975 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sellebjerg, H. S. Nielsen, J. L. Frederiksen, and J. Olesen A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis Neurology, April 1, 1999; 52(7): 1479 - 1479. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
